CD8A and neoplasm: In oncology, intratumoral LNPs delivering mRNA-2416 (OX40L) in murine H22 hepatocellular carcinoma resulted in tumor growth inhibition, amplified CD4+/CD8+ T-cell infiltration, and 50 % complete response rates, including immune memory upon rechallenge [203].